ProfileGDS4095 / 203917_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 62% 59% 63% 63% 61% 61% 64% 62% 59% 64% 63% 63% 62% 62% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep15.156762
GSM709769LY2 SRC1-siRNA tamoxifen treated rep34.7020759
GSM709765LY2 SRC1-siRNA untreated rep35.4049563
GSM709771LY2 SRC1-siRNA untreated rep15.2819763
GSM709772LY2 SRC1-siRNA untreated rep25.0413561
GSM709775LY2 SRC1-siRNA untreated rep44.9523261
GSM709764LY2 control-siRNA tamoxifen treated rep25.4658964
GSM709766LY2 control-siRNA tamoxifen treated rep35.0890162
GSM709768LY2 control-siRNA tamoxifen treated rep14.6369459
GSM709777LY2 control-siRNA tamoxifen treated rep45.461464
GSM709770LY2 control-siRNA untreated rep35.3455463
GSM709773LY2 control-siRNA untreated rep15.3975463
GSM709774LY2 control-siRNA untreated rep25.0846462
GSM709776LY2 control-siRNA untreated rep45.1976562